1. Home
  2. OLMA vs VLY Comparison

OLMA vs VLY Comparison

Compare OLMA & VLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • VLY
  • Stock Information
  • Founded
  • OLMA 2006
  • VLY 1927
  • Country
  • OLMA United States
  • VLY United States
  • Employees
  • OLMA N/A
  • VLY N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • VLY Major Banks
  • Sector
  • OLMA Health Care
  • VLY Finance
  • Exchange
  • OLMA Nasdaq
  • VLY Nasdaq
  • Market Cap
  • OLMA 465.4M
  • VLY 5.1B
  • IPO Year
  • OLMA 2020
  • VLY N/A
  • Fundamental
  • Price
  • OLMA $6.10
  • VLY $9.16
  • Analyst Decision
  • OLMA Strong Buy
  • VLY Hold
  • Analyst Count
  • OLMA 5
  • VLY 10
  • Target Price
  • OLMA $26.25
  • VLY $9.60
  • AVG Volume (30 Days)
  • OLMA 1.1M
  • VLY 5.5M
  • Earning Date
  • OLMA 11-12-2024
  • VLY 01-23-2025
  • Dividend Yield
  • OLMA N/A
  • VLY 4.79%
  • EPS Growth
  • OLMA N/A
  • VLY N/A
  • EPS
  • OLMA N/A
  • VLY 0.62
  • Revenue
  • OLMA N/A
  • VLY $1,577,035,000.00
  • Revenue This Year
  • OLMA N/A
  • VLY N/A
  • Revenue Next Year
  • OLMA N/A
  • VLY $7.09
  • P/E Ratio
  • OLMA N/A
  • VLY $14.70
  • Revenue Growth
  • OLMA N/A
  • VLY N/A
  • 52 Week Low
  • OLMA $5.56
  • VLY $6.47
  • 52 Week High
  • OLMA $16.78
  • VLY $11.18
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 27.05
  • VLY 31.05
  • Support Level
  • OLMA $5.56
  • VLY $8.90
  • Resistance Level
  • OLMA $6.87
  • VLY $10.27
  • Average True Range (ATR)
  • OLMA 0.81
  • VLY 0.33
  • MACD
  • OLMA -0.28
  • VLY -0.19
  • Stochastic Oscillator
  • OLMA 10.12
  • VLY 14.21

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About VLY Valley National Bancorp

Valley National Bancorp is a bank holding company whose principal wholly-owned subsidiary is Valley National Bank. It provides a full range of commercial, retail, and trust and investment services largely through its offices and ATM network throughout northern and central New Jersey, New York City Long Island, Florida, and Alabama. The segments of the group are commercial lending, consumer lending, investment management, and corporate and other adjustments, of which key interest income is derived from the commercial lending segment. In recent years, the company has focused on acquiring companies that operate outside of traditional banking and has emphasized wealth and capital management.

Share on Social Networks: